Diabetes Medication Adherence in Malaysia: Why Most Patients Fall Short and What to Do About It

Taking diabetes medication consistently and correctly is one of the most powerful things a person with type 2 diabetes can do to protect their long-term health. Yet research consistently shows that medication adherence among Malaysian diabetes patients is poor — with serious consequences for blood glucose control, complication rates, and healthcare costs.

This article examines the scale of the medication adherence problem in Malaysia, why patients stop or skip their medications, and what both patients and healthcare providers can do to improve it.

The Scale of the Problem in Malaysia

Medication non-adherence is one of the most significant but underaddressed challenges in Malaysian diabetes care. The numbers tell a sobering story:

Adherence to oral hypoglycaemic agents among Malaysian patients with type 2 diabetes is estimated at only 47% — meaning more than half of patients are not taking their medications as prescribed.
A 2023 cross-sectional study at a primary care clinic in Johor found that only 60.3% of participants were adherent to their diabetes medication, with a mean HbA1c of 8.3% — well above the target of 6.5%.
Among non-insulin-treated patients with HbA1c ≥8%, a retrospective analysis of the Malaysian National Diabetes Registry found that 54% had delayed treatment intensification, with a median delay of 13 months before their medications were stepped up.
Adherence to insulin therapy is even lower. A large cross-sectional study reported that only about 10% of Malaysian type 2 diabetes patients were treated with insulin at the time, despite many requiring it — partly driven by resistance to injectable therapy.

These numbers reflect a systemic gap between what is prescribed and what is actually taken — a gap with real clinical consequences.

Why Medication Adherence Matters So Much

The link between medication adherence and diabetes outcomes is direct and well-established. In the 2023 Johor study, medication adherence was significantly associated with good glycaemic control — adherent patients had a mean HbA1c of 7.9% compared to 8.7% among non-adherent patients. The difference of nearly 1% in HbA1c translates into meaningfully lower risk of retinopathy, nephropathy, neuropathy, and cardiovascular events over time.

Poor adherence leads to a predictable cascade: medications are not taken consistently → blood glucose remains elevated → HbA1c stays above target → tissue damage accumulates silently → complications develop years or decades later. By the time complications become symptomatic — vision loss, kidney failure, foot ulcers — the damage is already extensive and far more expensive to treat.

From a healthcare system perspective, poor adherence is enormously costly. Diabetes already costs Malaysia an estimated RM 3.1 billion annually. A significant portion of that cost is driven by complications that could have been prevented with consistent medication use and better glycaemic control.

Why Malaysian Patients Skip or Stop Their Medications

Medication non-adherence is rarely simple laziness. Research identifies a complex mix of patient-level, provider-level, and system-level barriers that vary by medication type, patient demographics, and clinical setting.

Barriers to oral hypoglycaemic medications

Side effects: Metformin — the most commonly prescribed first-line agent — commonly causes gastrointestinal side effects including nausea, bloating, and diarrhoea, particularly when first started or when doses are increased. Many patients reduce or stop their dose without informing their doctor.
Polypharmacy fatigue: Most Malaysian diabetes patients take multiple medications simultaneously — for blood glucose, blood pressure, cholesterol, and other conditions. Over 79% of patients in a large Malaysian cohort were on at least one antihypertensive, and most were also on lipid-lowering therapy. Managing a complex daily medication regimen is cognitively and practically demanding, particularly for elderly patients.
Traditional and complementary medicine (TCM): A significant proportion of Malaysian patients — studies estimate 17% or more — use traditional remedies or herbal supplements alongside or instead of prescribed medications, sometimes stopping conventional drugs entirely due to cultural preference or belief that traditional remedies are safer.
Perception that the medication is not working: Because good glycaemic control is asymptomatic — patients feel no different when their HbA1c drops from 9% to 7% — many patients cannot perceive the benefit of their medication. This makes it psychologically easier to skip doses.
Cost and access: While government clinics heavily subsidise diabetes medications, patients in rural areas, those attending private facilities, or those requiring newer drug classes (SGLT2 inhibitors, GLP-1 agonists) may face significant out-of-pocket costs that limit adherence.
Increasing age: Studies consistently show that increasing age is associated with medication non-adherence, likely due to cognitive decline, difficulties with complex regimens, and dependence on caregivers for medication management.
Malay ethnicity: The 2023 Johor study found Malay ethnicity to be independently associated with poorer glycaemic control. This likely reflects a complex interplay of dietary patterns (high carbohydrate and sugar intake), cultural food practices, and health literacy factors rather than adherence alone.

Barriers specific to insulin therapy

Insulin adherence faces an additional layer of barriers beyond those affecting oral medications:

Fear of injections (needle phobia): A study of Malaysian patients on insulin found that 14.5% cited fear of injection as a barrier to adherence.
Preference for oral therapy: 35.3% of insulin users expressed a preference for oral medication, reflecting ongoing resistance to injectable therapy even among those already prescribed insulin.
Misconceptions about insulin: Common myths include the belief that needing insulin means diabetes has become extremely severe, that insulin causes blindness or kidney failure (a reversal of causality — it is uncontrolled diabetes that causes these complications), or that insulin is addictive.
Hypoglycaemia fear: Concern about low blood sugar episodes — particularly in patients who have experienced symptomatic hypoglycaemia — leads many patients to deliberately underdose their insulin. The HAT (Hypoglycaemia Awareness Tool) study found that 1 in 3 insulin-treated Malaysian patients experienced hypoglycaemia, making this concern legitimate and requiring careful dose titration.
Injection technique and storage: Poor injection technique, incorrect storage of insulin (particularly in hot Malaysian weather), and inadequate patient education on insulin administration all contribute to inconsistent results and reduced motivation to continue.

What Improves Medication Adherence: Evidence-Based Strategies

For patients

Understand what your medication does — and doesn’t do. Oral diabetes medications and insulin do not cure diabetes. They work only as long as you take them. Missing doses does not “rest” the pancreas or provide a break — it simply allows blood glucose to rise unchecked, accelerating the damage that leads to complications.

Use the Medication Therapy Adherence Clinic (MTAC). Government hospitals and many primary care clinics in Malaysia offer MTAC services, where pharmacists provide individualised counselling on medication management, side effect mitigation, and dose optimisation. Despite being free and evidence-based, only 6.4% of insulin users in one Malaysian study had attended MTAC — a significantly underused resource.

Discuss side effects immediately. If metformin causes stomach upset or a medication makes you feel unwell, tell your doctor or pharmacist — do not simply stop the medication. In many cases, a dose adjustment, a change in timing (taking it with food), or a switch to an extended-release formulation resolves the problem completely.

Use pill organisers and reminders. For patients on multiple medications, a weekly pill organiser reduces missed doses significantly. Smartphone alarms, medication reminder apps, and linking tablet-taking to a fixed daily activity (morning tea, evening meal) all improve consistency.

Involve your family. Caregiver support is one of the strongest predictors of medication adherence, particularly for elderly patients. Family members who understand the medication regimen and actively support the patient have a measurable positive effect on adherence rates.

Self-monitor your blood glucose. Regular self-monitoring of blood glucose (SMBG) provides immediate feedback on how well medications are working. In one Malaysian study, SMBG was significantly associated with better insulin adherence — patients who monitored their own glucose were more motivated to take their medications because they could see the direct effect.

For healthcare providers

Address therapeutic inertia. The finding that 54% of Malaysian patients with HbA1c ≥8% experienced a 13-month delay in treatment intensification points to a system-level problem. When blood glucose targets are not being met, medication regimens need to be stepped up promptly — waiting and watching leads to prolonged periods of elevated glucose and accelerated complication development.

Simplify regimens where possible. Fixed-dose combination tablets that combine two drugs in a single pill reduce pill burden and improve adherence compared to separate tablets. Where clinically appropriate, once-daily dosing is preferred over twice or three times daily. Newer once-weekly injectable GLP-1 receptor agonists offer advantages over daily injections for appropriate patients.

Provide structured diabetes education. Patients who understand the mechanism of their medications, the consequences of non-adherence, and how to manage side effects are significantly more adherent. Structured diabetes self-management education (DSME) programmes — including group education sessions and individual counselling — are recommended by Malaysian CPG guidelines and should be offered to all patients, not just newly diagnosed ones.

Destigmatise insulin therapy. Many patients resist insulin because they view it as a failure or a sign of punishment. Healthcare providers should proactively frame insulin initiation as a natural progression of treatment and a tool that can dramatically improve quality of life — not a last resort.

The Bigger Picture: Treatment Inertia at Both Ends

Medication adherence failure in Malaysia operates at two levels simultaneously. Patients are not taking their prescribed medications consistently, and healthcare providers are not intensifying treatment promptly when targets are not being met. Both forms of inertia compound each other and result in the persistently suboptimal HbA1c levels seen across the Malaysian diabetes population — a mean HbA1c of 7.7% in the National Diabetes Registry 2023, with 31.2% of patients in a large cohort having HbA1c above 8.5%.

Closing this gap requires action at every level: better patient education, more proactive clinical management, system-level supports like MTAC expansion, and greater use of newer medications with once-daily or once-weekly dosing that reduce the burden of complex regimens. The tools to achieve better adherence exist — the challenge is closing the gap between what is possible and what is actually happening in practice.

References

Chin SS, Lau SW, et al. (2023). Medication adherence, its associated factors and implication on glycaemic control in patients with type 2 diabetes mellitus. Malaysian Family Physician. PMC10150324
Malaysian Endocrine and Metabolic Society (MEMS). (2024). Practical Guide to Insulin Therapy in Type 2 Diabetes Mellitus, 2nd Edition. mems.my
Lim LL, Hussein Z, et al. (2024). Real-world evaluation of care for type 2 diabetes in Malaysia: TARGET-T2D study. PLOS One. doi:10.1371/journal.pone.0296298
Ministry of Health Malaysia. (2023). National Diabetes Registry Report 2023. moh.gov.my
Insulin Adherence and Associated Factors in Patients with Type 2 Diabetes Mellitus Treated in Klang Primary Health Care Centres. PMC. PMC8715880
Ministry of Health Malaysia. Management of Type 2 Diabetes Mellitus, Clinical Practice Guideline, 6th Edition. moh.gov.my

This article is for general informational purposes. Patients should always consult their doctor, pharmacist, or diabetes educator before making any changes to their medication regimen.